Annual Drug Patent Expirations for SPINRAZA
Spinraza is a drug marketed by Biogen Idec and is included in one NDA. It is available from one supplier. There are nine patents protecting this drug.
This drug has five hundred and sixty-eight patent family members in thirty-two countries.
The generic ingredient in SPINRAZA is nusinersen sodium. One supplier is listed for this compound. Additional details are available on the nusinersen sodium profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
